NurExone Biologic Inc.’s Reverse Takeover Transaction

Gowling WLG advised NurExone Biologic Ltd. on the deal.NurExone Biologic Inc. (formerly, EnerSpar Corp.) (TSXV: NRX) (the “Company”) announced that it had completed its previously announced…

This content is for Standard 1 Year members only.
Login Join Now
Giulia Di Palma

Author: Giulia Di Palma

This content is for Standard 1 Year members only.
Login Join Now